ID   U255
AC   CVCL_JA36
SY   255 Bm
DR   Wikidata; Q54973631
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=4097745;
RX   PubMed=4104421;
CC   Population: Caucasian.
CC   Doubling time: 30-48 hours (PubMed=4097745); 36-48 hours (PubMed=4104421).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0566 ! U266B1
OI   CVCL_W412 ! U268
SX   Male
AG   53Y
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 6
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=4097745;
RA   Nilsson K., Bennich H., Johansson S.G.O., Ponten J.;
RT   "Established immunoglobulin producing myeloma (IgE) and lymphoblastoid
RT   (IgG) cell lines from an IgE myeloma patient.";
RL   Clin. Exp. Immunol. 7:477-489(1970).
//
RX   PubMed=4104421; DOI=10.1002/ijc.2910070303;
RA   Nilsson K.;
RT   "Characteristics of established myeloma and lymphoblastoid cell lines
RT   derived from an E myeloma patient: a comparative study.";
RL   Int. J. Cancer 7:380-396(1971).
//